Agency Forms Undergoing Paperwork Reduction Act Review, 14116-14117 [2021-05116]
Download as PDF
<![CDATA[
14116
Federal Register / Vol. 86, No. 47 / Friday, March 12, 2021 / Notices
available tobacco products. In addition,
this request seeks approval for
reinstating topics which have been
included in BRFSS in the past,
dependent upon state interest and
funding.
add the following topics to the
questionnaires: COVID vaccination,
impact of the COVID pandemic,
periodontal disease, additional
questions on heart attack and stroke,
disaster/pandemic preparedness,
veterans’ health and the use of newly
Participation is voluntary and there is
no cost to respondents to participate
other than their time. The average time
burden per response will be 22 minutes.
The total time burden across all
respondents will be approximately
287,798 hours.
ESTIMATED ANNUALIZED BURDEN HOURS
Form name
U.S. General Population ...................
Field Test Respondents (Adults >18
Years).
Landline Screener ............................
Cell Phone Screener ........................
Field Test Screener ..........................
BRFSS Core Survey by Phone
Interview.
BRFSS Optional Modules by Phone
Interview.
BRFSS Core Survey by Online Survey.
BRFSS Optional Modules by Online
Survey.
Field Test Survey by Phone Interview.
Total ...........................................
...........................................................
Annual Survey Respondents (Adults
>18 Years).
Jeffrey M. Zirger,
Lead, Information Collection Review Office,
Office of Scientific Integrity, Office of Science,
Centers for Disease Control and Prevention.
[FR Doc. 2021–05117 Filed 3–11–21; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[30Day–21–0931]
Agency Forms Undergoing Paperwork
Reduction Act Review
In accordance with the Paperwork
Reduction Act of 1995, the Centers for
Disease Control and Prevention (CDC)
has submitted the information
collection request titled ‘‘Blood Lead
Surveillance System (BLSS)’’ to the
Office of Management and Budget
(OMB) for review and approval. CDC
previously published a ‘‘Proposed Data
Collection Submitted for Public
Comment and Recommendations’’
notice on October 13, 2020, to obtain
comments from the public and affected
agencies. CDC did not receive comments
related to the previous notice. This
notice serves to allow an additional 30
days for public and affected agency
comments.
CDC will accept all comments for this
proposed information collection project.
The Office of Management and Budget
VerDate Sep<11>2014
17:04 Mar 11, 2021
Jkt 253001
Frm 00048
Fmt 4703
Total burden
(in hours)
173,000
694,000
900
480,000
1
1
1
1
1/60
1/60
1/60
15/60
2,884
11,567
15
120,000
440,000
1
15/60
110,000
100,000
1
10/60
16,666
80,000
1
10/60
13,333
500
1
45/60
13,333
........................
........................
........................
287,798
is particularly interested in comments
that:
(a) Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including
whether the information will have
practical utility;
(b) Evaluate the accuracy of the
agencies estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used;
(c) Enhance the quality, utility, and
clarity of the information to be
collected;
(d) Minimize the burden of the
collection of information on those who
are to respond, including, through the
use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology,
e.g., permitting electronic submission of
responses; and
(e) Assess information collection
costs.
To request additional information on
the proposed project or to obtain a copy
of the information collection plan and
instruments, call (404) 639–7570.
Comments and recommendations for the
proposed information collection should
be sent within 30 days of publication of
this notice to www.reginfo.gov/public/
do/PRAMain. Find this particular
information collection by selecting
‘‘Currently under 30-day Review—Open
for Public Comments’’ or by using the
PO 00000
Average
burden per
response
(in hours)
Number of
responses per
respondent
Number of
respondents
Type of respondents
Sfmt 4703
search function. Direct written
comments and/or suggestions regarding
the items contained in this notice to the
Attention: CDC Desk Officer, Office of
Management and Budget, 725 17th
Street NW, Washington, DC 20503 or by
fax to (202) 395–5806. Provide written
comments within 30 days of notice
publication.
Proposed Project
Blood Lead Surveillance System
(BLSS) (OMB Control No.0920–0931,
Exp. 05/31/2021)—Extension—National
Center for Environmental Health
(NCEH), Centers for Disease Control and
Prevention (CDC).
Background and Brief Description
The National Center for
Environmental Health (NCEH) is leading
an extension of the three-year
information collection request (ICR),
titled ‘‘Blood Lead Surveillance System
(BLSS)’’ (OMB Control No. 0920–0931,
Expiration Date 05/31/2021), which
covers two Centers for Disease Control
and Prevention (CDC) information
collections, one for childhood blood
lead surveillance by NCEH and another
for adult blood lead surveillance by the
National Institute for Occupational
Safety and Health (NIOSH).
The goal of the NCEH Childhood
Blood Lead Surveillance (CBLS)
Program is to support blood lead
screening and to promote primary
prevention of exposure to lead. Also, the
CBLS Program supports secondary
E:\FR\FM\12MRN1.SGM
12MRN1
14117
Federal Register / Vol. 86, No. 47 / Friday, March 12, 2021 / Notices
prevention of adverse health effects
when lead exposures occur in children,
through improved program management
and oversight in respondent
jurisdictions. The goal of the NIOSH
Adult Blood Lead Epidemiology and
Surveillance (ABLES) Program is to
build state capacity for adult blood lead
surveillance programs to measure trends
in adult blood lead levels and to prevent
lead over-exposures. Thus, blood lead
surveillance over the human lifespan is
covered under this single information
collection request (ICR), specifically for
children younger than 16 years through
CBLS at NCEH, and for adults 16 years
and older, through ABLES at NIOSH.
NCEH has a three-year cooperative
agreement, titled ‘‘Lead Poisoning
Prevention—Childhood Lead Poisoning
Prevention—financed partially by
Prevention and Public Health Funds’’—
(Funding Opportunity Announcement
[FOA] No. CDC–RFA–EH17–
1701PPHF17) and a two-year
cooperative agreement, titled
‘‘Childhood Lead Poisoning Prevention
Projects, State and Local Childhood
Lead Poisoning Prevention and
Surveillance of Blood Lead Levels in
Children’’—(Notice of Funding
Opportunity [NOFO] No. CDC–RFA–
EH18–1806). Both have one-year
extensions (CDC–RFA–EH17–
1701SUPP20 and CDC–RFA–EH18–
1806 SUPP20, respectively). The first
year of this ICR will extend through the
first eight months of the FY21 and thus
will be covered by the aforementioned
one-year extensions, while the second
and third years of this ICR will be
considered in future fiduciary
appraisals. States voluntarily participate
by sharing adult BLL data received from
testing laboratories with NIOSH ABLES.
Over the past several decades there
have been substantial efforts in
environmental lead abatement,
improved protection from occupational
lead exposure, and a reduction in the
prevalence of population blood lead
levels (BLLs) over time. The U.S.
population BLLs have substantially
decreased over the last four decades. For
example, the CDC has reported the
1976–1980 U.S. mean BLL in children
six months to five years was 16.0
micrograms per deciliter (mcg/dL), and
14.1 mcg/dL among adults 18 to 74
years. More recently, the CDC reported
the 2009–2010 U.S. BLL geometric
means among children one to five years
and among adults 20 years and older as
1.2 mcg/dL for both age groups.
In 2012, the National Toxicology
Program (NTP) concluded that there is
sufficient evidence that even BLLs less
than 5 mcg/dL are associated with
adverse health effects in both children
and adults. Despite the reduction in the
overall population BLL over four
decades, lead exposures continue to
occur at unacceptable levels for
individuals in communities and
workplaces across the nation.
Surveillance will continue through
CBLS and ABLES to identify cases of
elevated BLLs when primary prevention
is not achieved. As of 2015, NCEH
defines its blood lead reference level for
children as 5 mcg/dL. NIOSH defines an
elevated BLLs as greater than or equal
to 5 mcg/dL for adults.
Respondents are defined as state,
local, and territorial health departments
with lead poisoning prevention
programs. The estimated annual time
burden for NCEH CBLS is 946 hours.
The estimated annual time burden for
NIOSH ABLES is 280 hours. In total,
CDC is requesting approval for a total
annual time burden of 1,226 hours.
ESTIMATED ANNUALIZED BURDEN HOURS
Number of
respondents
Number of
responses
per
respondent
Average
burden
per response
(in hours)
Type of respondents
Form name
State or Local Health Departments, or their
Bona Fide Agents.
CBLS Variables (ASCII Text Files) ................
59
4
4
CBLS Aggregate Records Form (Excel) ........
ABLES Case Records Form ..........................
ABLES Aggregate Records Form ..................
1
32
8
1
1
1
2
8
3
Jeffrey M. Zirger,
Lead, Information Collection Review Office,
Office of Scientific Integrity, Office of Science,
Centers for Disease Control and Prevention.
[FR Doc. 2021–05116 Filed 3–11–21; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[60Day–2021–0556; Docket No. CDC–2021–
0022]
Proposed Data Collection Submitted
for Public Comment and
Recommendations
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice with comment period.
AGENCY:
VerDate Sep<11>2014
17:04 Mar 11, 2021
Jkt 253001
The Centers for Disease
Control and Prevention (CDC), as part of
its continuing effort to reduce public
burden and maximize the utility of
government information, invites the
general public and other Federal
agencies the opportunity to comment on
a proposed and/or continuing
information collection, as required by
the Paperwork Reduction Act of 1995.
This notice invites comment on a
continuing information collection
project titled Assisted Reproductive
Technology (ART) Program Reporting
System. This study is designed to
collect information on ART cycles to
publish information on pregnancy
success rates as required under Section
2(a) of the Federal Clinic Success Rate
and Certification Act (FCSRCA).
SUMMARY:
CDC must receive written
comments on or before May 11, 2021.
DATES:
PO 00000
Frm 00049
Fmt 4703
Sfmt 4703
You may submit comments,
identified by Docket No. CDC–2021–
0022 by any of the following methods:
• Federal eRulemaking Portal:
Regulations.gov. Follow the instructions
for submitting comments.
• Mail: Jeffrey M. Zirger, Information
Collection Review Office, Centers for
Disease Control and Prevention, 1600
Clifton Road NE, MS–D74, Atlanta,
Georgia 30329.
Instructions: All submissions received
must include the agency name and
Docket Number. CDC will post, without
change, all relevant comments to
Regulations.gov.
Please note: Submit all comments
through the Federal eRulemaking portal
(regulations.gov) or by U.S. mail to the
address listed above.
FOR FURTHER INFORMATION CONTACT: To
request more information on the
proposed project or to obtain a copy of
the information collection plan and
ADDRESSES:
E:\FR\FM\12MRN1.SGM
12MRN1
]]>Agencies
[Federal Register Volume 86, Number 47 (Friday, March 12, 2021)]
[Notices]
[Pages 14116-14117]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-05116]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[30Day-21-0931]
Agency Forms Undergoing Paperwork Reduction Act Review
In accordance with the Paperwork Reduction Act of 1995, the Centers
for Disease Control and Prevention (CDC) has submitted the information
collection request titled ``Blood Lead Surveillance System (BLSS)'' to
the Office of Management and Budget (OMB) for review and approval. CDC
previously published a ``Proposed Data Collection Submitted for Public
Comment and Recommendations'' notice on October 13, 2020, to obtain
comments from the public and affected agencies. CDC did not receive
comments related to the previous notice. This notice serves to allow an
additional 30 days for public and affected agency comments.
CDC will accept all comments for this proposed information
collection project. The Office of Management and Budget is particularly
interested in comments that:
(a) Evaluate whether the proposed collection of information is
necessary for the proper performance of the functions of the agency,
including whether the information will have practical utility;
(b) Evaluate the accuracy of the agencies estimate of the burden of
the proposed collection of information, including the validity of the
methodology and assumptions used;
(c) Enhance the quality, utility, and clarity of the information to
be collected;
(d) Minimize the burden of the collection of information on those
who are to respond, including, through the use of appropriate
automated, electronic, mechanical, or other technological collection
techniques or other forms of information technology, e.g., permitting
electronic submission of responses; and
(e) Assess information collection costs.
To request additional information on the proposed project or to
obtain a copy of the information collection plan and instruments, call
(404) 639-7570. Comments and recommendations for the proposed
information collection should be sent within 30 days of publication of
this notice to www.reginfo.gov/public/do/PRAMain. Find this particular
information collection by selecting ``Currently under 30-day Review--
Open for Public Comments'' or by using the search function. Direct
written comments and/or suggestions regarding the items contained in
this notice to the Attention: CDC Desk Officer, Office of Management
and Budget, 725 17th Street NW, Washington, DC 20503 or by fax to (202)
395-5806. Provide written comments within 30 days of notice
publication.
Proposed Project
Blood Lead Surveillance System (BLSS) (OMB Control No.0920-0931,
Exp. 05/31/2021)--Extension--National Center for Environmental Health
(NCEH), Centers for Disease Control and Prevention (CDC).
Background and Brief Description
The National Center for Environmental Health (NCEH) is leading an
extension of the three-year information collection request (ICR),
titled ``Blood Lead Surveillance System (BLSS)'' (OMB Control No. 0920-
0931, Expiration Date 05/31/2021), which covers two Centers for Disease
Control and Prevention (CDC) information collections, one for childhood
blood lead surveillance by NCEH and another for adult blood lead
surveillance by the National Institute for Occupational Safety and
Health (NIOSH).
The goal of the NCEH Childhood Blood Lead Surveillance (CBLS)
Program is to support blood lead screening and to promote primary
prevention of exposure to lead. Also, the CBLS Program supports
secondary
[[Page 14117]]
prevention of adverse health effects when lead exposures occur in
children, through improved program management and oversight in
respondent jurisdictions. The goal of the NIOSH Adult Blood Lead
Epidemiology and Surveillance (ABLES) Program is to build state
capacity for adult blood lead surveillance programs to measure trends
in adult blood lead levels and to prevent lead over-exposures. Thus,
blood lead surveillance over the human lifespan is covered under this
single information collection request (ICR), specifically for children
younger than 16 years through CBLS at NCEH, and for adults 16 years and
older, through ABLES at NIOSH.
NCEH has a three-year cooperative agreement, titled ``Lead
Poisoning Prevention--Childhood Lead Poisoning Prevention--financed
partially by Prevention and Public Health Funds''--(Funding Opportunity
Announcement [FOA] No. CDC-RFA-EH17-1701PPHF17) and a two-year
cooperative agreement, titled ``Childhood Lead Poisoning Prevention
Projects, State and Local Childhood Lead Poisoning Prevention and
Surveillance of Blood Lead Levels in Children''--(Notice of Funding
Opportunity [NOFO] No. CDC-RFA-EH18-1806). Both have one-year
extensions (CDC-RFA-EH17-1701SUPP20 and CDC-RFA-EH18-1806 SUPP20,
respectively). The first year of this ICR will extend through the first
eight months of the FY21 and thus will be covered by the aforementioned
one-year extensions, while the second and third years of this ICR will
be considered in future fiduciary appraisals. States voluntarily
participate by sharing adult BLL data received from testing
laboratories with NIOSH ABLES.
Over the past several decades there have been substantial efforts
in environmental lead abatement, improved protection from occupational
lead exposure, and a reduction in the prevalence of population blood
lead levels (BLLs) over time. The U.S. population BLLs have
substantially decreased over the last four decades. For example, the
CDC has reported the 1976-1980 U.S. mean BLL in children six months to
five years was 16.0 micrograms per deciliter (mcg/dL), and 14.1 mcg/dL
among adults 18 to 74 years. More recently, the CDC reported the 2009-
2010 U.S. BLL geometric means among children one to five years and
among adults 20 years and older as 1.2 mcg/dL for both age groups.
In 2012, the National Toxicology Program (NTP) concluded that there
is sufficient evidence that even BLLs less than 5 mcg/dL are associated
with adverse health effects in both children and adults. Despite the
reduction in the overall population BLL over four decades, lead
exposures continue to occur at unacceptable levels for individuals in
communities and workplaces across the nation. Surveillance will
continue through CBLS and ABLES to identify cases of elevated BLLs when
primary prevention is not achieved. As of 2015, NCEH defines its blood
lead reference level for children as 5 mcg/dL. NIOSH defines an
elevated BLLs as greater than or equal to 5 mcg/dL for adults.
Respondents are defined as state, local, and territorial health
departments with lead poisoning prevention programs. The estimated
annual time burden for NCEH CBLS is 946 hours.
The estimated annual time burden for NIOSH ABLES is 280 hours. In
total, CDC is requesting approval for a total annual time burden of
1,226 hours.
Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
Number of Average burden
Type of respondents Form name Number of responses per per response
respondents respondent (in hours)
----------------------------------------------------------------------------------------------------------------
State or Local Health Departments, or CBLS Variables (ASCII 59 4 4
their Bona Fide Agents. Text Files).
CBLS Aggregate Records 1 1 2
Form (Excel).
ABLES Case Records Form. 32 1 8
ABLES Aggregate Records 8 1 3
Form.
----------------------------------------------------------------------------------------------------------------
Jeffrey M. Zirger,
Lead, Information Collection Review Office, Office of Scientific
Integrity, Office of Science, Centers for Disease Control and
Prevention.
[FR Doc. 2021-05116 Filed 3-11-21; 8:45 am]
BILLING CODE 4163-18-P
